Cargando…

Angiotensin II Mediates Cardiomyocyte Hypertrophy in Atrial Cardiomyopathy via Epigenetic Transcriptional Regulation

AIMS: European Heart Rhythm Association established an expert consensus to define, characterize, and classify atrial cardiomyopathy into four subgroups based on their histopathological features. The predominant pathological feature of classes I and III is the hypertrophy of atrial cardiomyocytes. He...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Liuying, Wang, Jin, Zhang, Rui, Zhang, Yingyi, Geng, Jie, Cao, Lu, Zhao, Xiaoyun, Geng, Jianhui, Du, Xinping, Hu, Yuecheng, Cong, Hongliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232324/ https://www.ncbi.nlm.nih.gov/pubmed/35756425 http://dx.doi.org/10.1155/2022/6312100

Ejemplares similares

Effect of SKF-96365 on cardiomyocyte hypertrophy induced by angiotensin II
por: Cheng, Huijun, et al.
Publicado: (2020)

Herpud1 suppress angiotensin II induced hypertrophy in cardiomyocytes
por: Mikawa, Mei, et al.
Publicado: (2022)

Effect of hepatocyte growth factor and angiotensin II on rat cardiomyocyte hypertrophy
por: Chen, Ai-Lan, et al.
Publicado: (2012)

The role of mAKAPβ in the process of cardiomyocyte hypertrophy induced by angiotensin II
por: GUO, HUIXIN, et al.
Publicado: (2015)

Nelumbo nucifera Receptaculum Extract Suppresses Angiotensin II-Induced Cardiomyocyte Hypertrophy
por: Cho, Soyoung, et al.
Publicado: (2019)

Flow reserve fraction: the optimal choice in lesion assessing and interventional guiding for patient with unstable angina pectoris and intermediate lesion wrapped with myocardial bridge: a case report
por: Hu, Yuecheng, et al.
Publicado: (2021)

Crosstalk between AMPK activation and angiotensin II-induced hypertrophy in cardiomyocytes: the role of mitochondria
por: Hernández, Jessica Soto, et al.
Publicado: (2014)

An MRTF-A–Sp1–PDE5 Axis Mediates Angiotensin-II-Induced Cardiomyocyte Hypertrophy
por: Wu, Teng, et al.
Publicado: (2020)

Cytosolic CARP Promotes Angiotensin II- or Pressure Overload-Induced Cardiomyocyte Hypertrophy through Calcineurin Accumulation
por: Chen, Ci, et al.
Publicado: (2014)

Left ventricular hypertrophy with cardiomyocyte atrophy and extensive interstitial fibrosis: a mitochondrial cardiomyopathy
por: Zhang, Xinyu, et al.
Publicado: (2022)

Corrigendum: An MRTF-A–Sp1–PDE5 Axis Mediates Angiotensin-II-Induced Cardiomyocyte Hypertrophy
por: Wu, Teng, et al.
Publicado: (2021)

Rap1GAP Mediates Angiotensin II-Induced Cardiomyocyte Hypertrophy by Inhibiting Autophagy and Increasing Oxidative Stress
por: Gao, Yan, et al.
Publicado: (2021)

Metformin attenuates angiotensin II-induced cardiomyocyte hypertrophy by upregulating the MuRF1 and MAFbx pathway
por: Du, Fawang, et al.
Publicado: (2021)

Crim1 inhibits angiotensin II-induced hypertrophy and preserves Kv4.2 expression in cardiomyocytes
por: He, Jionghong, et al.
Publicado: (2022)

Adenoviral Delivery of Angiotensin-(1-7) or Angiotensin-(1-9) Inhibits Cardiomyocyte Hypertrophy via the Mas or Angiotensin Type 2 Receptor
por: Flores-Muñoz, Monica, et al.
Publicado: (2012)

Hypertrophy of unaffected cardiomyocytes correlates with severity of cardiomyopathy in female patients with Fabry disease
por: Chimenti, Cristina, et al.
Publicado: (2021)

Fibin regulates cardiomyocyte hypertrophy and causes protein-aggregate-associated cardiomyopathy in vivo
por: Petersen, Matthias, et al.
Publicado: (2023)

Macrophage-Derived Exosomal Mir-155 Regulating Cardiomyocyte Pyroptosis and Hypertrophy in Uremic Cardiomyopathy
por: Wang, Bin, et al.
Publicado: (2020)

SIRT1 Functions as an Important Regulator of Estrogen-Mediated Cardiomyocyte Protection in Angiotensin II-Induced Heart Hypertrophy
por: Shen, Tao, et al.
Publicado: (2014)

Activating transcription factor 3 inhibits angiotensin II-induced cardiomyocyte viability and fibrosis by activating the transcription of cysteine-rich angiogenic protein 61
por: Zhang, Yu, et al.
Publicado: (2022)

Direct Actions of AT(1) (Type 1 Angiotensin) Receptors in Cardiomyocytes Do Not Contribute to Cardiac Hypertrophy
por: Sparks, Matthew A., et al.
Publicado: (2021)

Deficit of glucocorticoid‐induced leucine zipper amplifies angiotensin‐induced cardiomyocyte hypertrophy and diastolic dysfunction
por: Cappetta, Donato, et al.
Publicado: (2020)

Increased Postnatal Cardiac Hyperplasia Precedes Cardiomyocyte Hypertrophy in a Model of Hypertrophic Cardiomyopathy
por: Farrell, Emily T., et al.
Publicado: (2017)

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Is the Extent of Septal Hypertrophy Important?
por: Park, Kyoung-min, et al.
Publicado: (2016)

Sulforaphane prevents angiotensin II‐induced cardiomyopathy by activation of Nrf2 through epigenetic modification
por: Su, Xuling, et al.
Publicado: (2021)

The Inhibitory Effect of WenxinKeli on H9C2 Cardiomyocytes Hypertrophy Induced by Angiotensin II through Regulating Autophagy Activity
por: Li, Jie, et al.
Publicado: (2017)

Lycopene Inhibits Urotensin-II-Induced Cardiomyocyte Hypertrophy in Neonatal Rat Cardiomyocytes
por: Chao, Hung-Hsing, et al.
Publicado: (2014)

Amlexanox and Forskolin Prevents Isoproterenol-Induced Cardiomyopathy by Subduing Cardiomyocyte Hypertrophy and Maladaptive Inflammatory Responses
por: Adzika, Gabriel Komla, et al.
Publicado: (2021)

Lercanidipine attenuates angiotensin II-induced cardiomyocyte hypertrophy by blocking calcineurin-NFAT3 and CaMKII-HDAC4 signaling
por: Chen, Yuezhang, et al.
Publicado: (2017)

Sacubitril/Valsartan Inhibits Cardiomyocyte Hypertrophy in Angiotensin II-Induced Hypertensive Mice Independent of a Blood Pressure-Lowering Effect
por: Tashiro, Kohei, et al.
Publicado: (2020)

Catalase Mediates the Inhibitory Actions of PPARδ against Angiotensin II-Triggered Hypertrophy in H9c2 Cardiomyocytes
por: Hwang, Jung Seok, et al.
Publicado: (2021)

Rutin Modulates MAPK Pathway Differently from Quercetin in Angiotensin II-Induced H9c2 Cardiomyocyte Hypertrophy
por: Siti, Hawa Nordin, et al.
Publicado: (2021)

Liquiritin Attenuates Angiotensin II-Induced Cardiomyocyte Hypertrophy via ATE1/TAK1-JNK1/2 Pathway
por: Mo, Jiajia, et al.
Publicado: (2022)

Transcriptional bursts and heterogeneity among cardiomyocytes in hypertrophic cardiomyopathy
por: Burkart, Valentin, et al.
Publicado: (2022)

Src Is Required for Mechanical Stretch-Induced Cardiomyocyte Hypertrophy through Angiotensin II Type 1 Receptor-Dependent β-Arrestin2 Pathways
por: Wang, Shijun, et al.
Publicado: (2014)

Cannabinoid receptor agonist attenuates angiotensin II–induced enlargement and mitochondrial dysfunction in rat atrial cardiomyocytes
por: Altieri, Danielle I., et al.
Publicado: (2023)

MiR-410-3p facilitates Angiotensin II–induced cardiac hypertrophy by targeting Smad7
por: Jia, Guizhi, et al.
Publicado: (2021)

Angiotensin II Receptor Blockers and Arrhythmias in Ventricular Hypertrophy
por: Salama, Guy
Publicado: (2022)

Angiotensin II receptor blockers and cardiovascular protection: Focus on left ventricular hypertrophy regression and atrial fibrillation prevention
por: Cuspidi, Cesare, et al.
Publicado: (2008)

Characteristics of left atrial remodeling in patients with atrial fibrillation and hypertrophic cardiomyopathy in comparison to patients without hypertrophy
por: Nedios, Sotirios, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_18gl13alsuemnloguchtc1tuu7